NewAmsterdam Pharma Company NV - Warrants (15/11/2027) OverviewNewAmsterdam Pharma Company NV - Warrants (15/11/2027) Selling, General & Admin
Selling, General & Admin expenses for NAMSW.
Quarterly SG&A Expenses
$23.45M
↓ 13.63% YoY
As of Mar 31, 2026
Annual SG&A Expenses (TTM)
$102.59M
↑ 18.81% YoY
Trailing 12 months ending Mar 31, 2026